Elucidation of the molecular mechanism of action of selective estrogen receptor modulators

American Journal of Cardiology

Volumn 90, Issue 1 SUPPL. 1, 2002, Pages F35-F43

  McDonnell, Donald P ^a   Wijayaratne, Ashini ^a   Chang, Ching yi ^a   Norris, John D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1,2 DIPHENYL 1 BUTENYL)CINNAMIC ACID; 4 HYDROXYTAMOXIFEN; DNA; DROLOXIFENE; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; ISOPROTEIN; LIGAND; RALOXIFENE; RECEPTOR SUBTYPE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; STEROID RECEPTOR COACTIVATOR 1; TAMOXIFEN;

CONFERENCE PAPER; DNA BINDING; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; HUMAN; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; TISSUE SPECIFICITY;

EID: 0037014409     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)02221-4     Document Type: Conference Paper

References (29)

1. Actions of ovarian steroid hormones
2. A new derivative of triphenylethylene: Effect on implantation and mode of action in rats
3. Tamoxifen is a potent "pure" anti-oestrogen in chick oviduct
4. Dose-dependent effects of tamoxifen on long bones in growing rats: Influence of ovarian status
5. Clomiphene protects against osteoporosis in the mature ovariectomized rat
6. Tamoxifen prevents the skeletal effects of ovarian hormone deficiency in rats
7. Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer
8. Other selective oestrogen receptor modulators (SERMs) in development
9. Cloning of a novel estrogen receptor expressed in rat prostate and ovary
10. Selective estrogen receptor modulators
11. Estrogen receptor null mice: What have we learned and where will they lead us?
12. The estrogen receptor β-isoform (ERβ) of the human estrogen receptor modulates ERα transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens
13. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β
14. Steroid hormone receptors compete for factors that mediate their enhancer function
15. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions
16. Ligand-dependent conformational changes in the progesterone receptor are necessary for events that follow DNA binding
17. Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation
18. Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain
19. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens
20. Molecular basis of agonism and antagonism in the oestrogen receptor
21. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
22. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily
23. An issue of tissues: Divining the split personalities of selective estrogen receptor modulators
24. Nuclear receptor coregulators: Cellular and molecular biology
25. Ligand-independent activation of the oestrogen receptor by mutation of a conserved tyrosine
26. Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: Discovery of peptide antagonists of estrogen receptors α and β
27. Peptide antagonists of the human estrogen receptor
28. Mechanistic complexities in endocrine modulation: Estrogen receptor structure, modulators, and targets